港股收盘 | 恒指收涨0.92% “锂业双雄”异动走强 中资券商股尾盘拉升

Market Overview - The Federal Reserve's mixed non-farm data has led to increased expectations for interest rate cuts, resulting in a volatile sentiment in the Hong Kong stock market, which opened lower but ended positively with the Hang Seng Index rising by 0.92% to 25,468.78 points and a total turnover of HKD 183.14 billion [1] - The forward P/E ratio of the Hang Seng Index is currently at 12.7 times, down 5% from its year-to-date peak, indicating a potential period of market consolidation without new catalysts [1] Blue-Chip Performance - Li Ning (02331) saw a notable increase of 4.26%, closing at HKD 19.07 with a turnover of HKD 613 million, contributing 2.91 points to the Hang Seng Index. The opening of its first global flagship store and the launch of a new product line are expected to enhance brand influence [2] - Other blue-chip stocks such as China Life (02628) and Pop Mart (09992) also performed well, rising by 4.31% and 3.44% respectively, while New Energy (02688) and Techtronic Industries (00669) faced declines [2] Sector Highlights - The airline sector continued its upward trend, with major airlines reporting strong passenger load factors for November. China Eastern Airlines (00753) reported a load factor of 87.37%, up 3.04 percentage points year-on-year [4] - The lithium sector saw significant movements, with Tianqi Lithium (09696) and Ganfeng Lithium (01772) both rising over 5% amid news of mining rights cancellations in Yichun, which may impact supply dynamics [5][6] Brokerage Sector - Chinese brokerage stocks experienced a rally, with CITIC Securities (06030) rising by 3.4% and other major firms also seeing gains. The recent announcements of dividend distributions by several brokerages have contributed to market activity [6][7] - The ongoing supportive policies for the capital market are expected to enhance the sector's performance, with a focus on wealth management transformation and international business expansion [6] Notable Stock Movements - Zhaoyan New Drug (06127) surged by 10.36% due to increased demand for preclinical testing resources, particularly experimental monkeys, which are in short supply [8] - Drug developer Yaojie Ankang-B (02617) rose by 17.41% following positive clinical trial results for its core product, which has received multiple orphan drug designations [9] - Yidu International (00259) faced a decline of 8.44%, attributed to market reactions following the IPO of a related company [10]